首頁 › 非小細胞肺癌 › 德克薩斯州 › The Woodlands
The Woodlands, TX 的 非小細胞肺癌 臨床試驗
15 項針對 非小細胞肺癌 的研究正在 The Woodlands（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Houston Methodist The Woodlands Hospital, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- The University of Texas MD Anderson Cancer Center - Conroe, Conroe · 距離 11 英里
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
招募中3 期
- Texas Oncology - Gulf Coast, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- Texas Oncology - Gulf Coast, The Woodlands
- The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe · 距離 11 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Texas Oncology - Gulf Coast, The Woodlands
- Kelsey-Seybold Clinic - Springwoods Village Campus, Spring · 距離 7 英里
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Community Clinical Trials, Spring · 距離 7 英里
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
招募中3 期
- Renovatio Clinical, The Woodlands
- Woodlands Radiology, The Woodlands
- The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe · 距離 11 英里
- 還有 1 項
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- USO - US Oncology Research Network, The Woodlands
Pan-tumor MRD Study
招募中觀察性研究
- Community Clinical Trials, Kingwood · 距離 20 英里
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
招募中3 期
- Research Site, Kingwood · 距離 20 英里
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
招募中3 期
- Research Site, Kingwood · 距離 20 英里
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- USOR - Texas Oncology - The Woodlands, The Woodlands
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
招募中3 期
- Lumi Research, Kingwood · 距離 20 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- Renovatio Clinical, The Woodlands
- Community Clinical Trials, Kingwood · 距離 20 英里
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
招募中2 期
- MD Anderson The Woodlands, Conroe · 距離 11 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
The Woodlands 的其他研究
- 肥胖症12 項研究
- 過重10 項研究
- 乳癌10 項研究
- 黃斑部病變9 項研究
- 心血管疾病9 項研究
- 轉移性癌症9 項研究
- 第二型糖尿病7 項研究
- 心臟衰竭7 項研究
- 肺癌7 項研究
- 動脈硬化6 項研究
- 地圖樣萎縮6 項研究
- 前列腺癌6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。